ROLL CALL VOTES 1) Confirmation of Executive Calendar #646 the nomination of Jeremy C. Stein, of MA, to be a Member of the Board of Governors of the Federal Reserve System; Confirmed: 70-24 2) Confirmation of Executive Calendar #647, the nomination of Jerome H. Powell, of MD, to be a Member of the Board of Governors of…
There will be no further roll call votes during Thursday’s session of the Senate.
Senator Reid asked unanimous consent to take up and pass H.R.1905, as amended by the text of the Reid-Johnson (SD)-Shelby amendment, which is the text of S.2101, and the Reid-Johnson (SD)-Shelby amendment. Senator Kyl objected.
Senator Reid also filed cloture on the motion to proceed to Legislative Calendar #400, S.3187, the FDA Safety and Innovation Act.
Senator Reid filed cloture on the nomination of Paul J. Watford, of California, to be United State District Judge for the 9th Circuit. Senators should expect the cloture vote at approximately 5:30pm on Monday, May, 21.
12:28pm The Senate began a roll call vote on Executive Calendar #647, the nomination of Jerome H. Powell, of MD, to be a Member of the Board of Governors of the Federal Reserve System; Confirmed: 74-21
12:01pm The Senate began a roll call vote on confirmation of Executive Calendar #646 the nomination of Jeremy C. Stein, of MA, to be a Member of the Board of Governors of the Federal Reserve System; Confirmed: 70-24
Washington, D.C. – Nevada Senator Harry Reid spoke on the Senate floor today regarding the Food and Drug Administration Safety and Innovation Act. Below are his remarks as prepared for delivery: When someone we love gets sick the only thing on our minds is how to help them get them well – how to get…
At 10:30am, the Senate will proceed to Executive Session with 90 minutes for debate prior to votes on confirmation of the following nominations: - Executive Calendar #646, Jeremy C. Stein, of Massachusetts, to be a Member of the Board of Governors of the Federal Reserve System for the unexpired term of fourteen years from February…
The Senate is considering the motion to proceed to S.3187, A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. The time until 10:30am is equally divided and…